Offering Routine and Rapid Point of Care (POC) Syphilis Testing in Pregnant Patients Presenting to the Emergency Department
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT06645106
- Status
- Recruiting
Conditions
- Syphilis
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 50 Years
- Healthy Volunteers
- Not accepted
Interventions
- Rapid Point of Care (POC) Syphilis testing — DEVICEParticipants will undergo the point of care (POC) FDA cleared syphilis health check (SHC) POC test by a research staff using 50 microliters or 1-3 drops of whole blood via finger stick. The analyzer is handheld, and all testing equipment is temperature stable and does not need refrigeration. The SHC-Syphilis results will be available within 10 minutes of receipt given the published turnaround time to results of 15 minutes per package insert and will be recorded as a research note in the electronic medical record (EMR) while the provider assigned to the patient and the Houston Health Department will be notified of results and further treatment will be done if results are positive.
Study Details
The purpose of this study is to offer routine lab-based and rapid point of care (POC) syphilis diagnostic testing in the emergency department (ED) and obstetrical (OB) triage , thereby increasing screening and treatment initiation for pregnant patients without prenatal care or with no documented syphilis results during the index pregnancy in other to increase rates of full treatment to determine if the implementation of a robust linkage to care program for pregnant patients with positive rapid POC results will more likely result in complete treatment for all stages of syphilis and adherence to recommended maternal and newborn longitudinal follow up and to assess factors that contribute to treatment completion after implementation of the intervention will also be analyzed to tailor efforts targeting social and healthcare navigation factors that affect health equity; including poverty, insurance, health literacy and others.
Key Dates
- Start date
- Feb 4, 2025
- Status verified
- May 2026
- Primary completion
- Feb 1, 2028
- Completion
- Feb 1, 2028
Study Design
- Enrollment
- 1,500 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Rapid Point of Care (POC) Syphilis testing
Primary Outcome Measure
Percentage of patients without prenatal care during the index pregnancy who received full treatment for all stages of syphilis [ Time Frame: within 1 week of presentation until the time of delivery ]
Central Contacts
- Irene Stafford, MD(713) 500-6412
- Carrie Bakunas, MD(713) 500-7878
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 |
Find similar trials in Houston, TX
Related Studies
- Modernizing Perinatal Syphilis TestingRecruiting · The University of Texas Health Science Center, Houston · Los Angeles, California
- Doxycycline Prophylaxis for Prevention of Sexually Transmitted InfectionsPHASE4 · Recruiting · Westat · Los Angeles, California
- Cefixime Clinical TrialPHASE3 · Recruiting · University of Southern California · Los Angeles, California
- A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis DisparitiesRecruiting · Tulane University · New Orleans, Louisiana